Uranium stocks are ending the week on a strong note, with shares of Cameco (NYSE: CCJ) stock up 5.8% through 10 a.m. ET and smaller rivals Ur-Energy(NYSEMKT: URG), Uranium Royalty (NASDAQ: UROY), and UraniumEnergy(NYSEMKT: UEC) doing even better -- up 8.2%, 9.9%, and 12.7%, respectively. And all four of these nuclear stocks have just one company to thank for their rallies: Kazakhstan's Kazatomprom. What Kazatomprom said today As The Financial Times pointed out this morning, Kazatomprom (literally an abbreviation of "Kazakhstan atomic industry") is the world's largest producer of uranium for nuclear power. Problem is, it's planning to become a smaller producer of uranium as early as next year. Citing "project delays and sulphuric acid shortages," Kazatomprom cut its uranium production target for 2025 by 17%, to a range of 25,000 to 26,500 metric tons. With Kazatomprom responsible for roughly 20% of world output, that means that global supplies of uranium -- which were already constrained thanks to Russia's war in Ukraine -- will fall by another 3% to 4% next year. Worse, FT cites a Canaccord Genuity analyst warning that Kazatomprom's forecast could turn out to be optimistic. Canaccord estimates that Kazatomprom will produce closer to 23,000 tons of uranium next year, constricting global supplies even further. Further, Canaccord observed that Kazatomprom has very few reserves to blunt the impact of a 2025 production cut. Rising demand for uranium has depleted the company's reserves of uranium already mined and ready for shipment by 31% so far this year. Should you buy uranium stocks? Long story short: Kazatomprom can't produce enough uranium to meet global nuclear power plant needs, so other uranium producers will need to increase their own production to fill the gap. The good news for investors is that this will mean higher prices for uranium and probably more profits for those who own shares in Cameco, Ur-Energy, Uranium Royalty, and Uranium Energy -- at least for a time. According to Trading Economics data, the spot price on uranium today sits just under $80 per pound, down from roughly $105 per pound in February. That's already comfortably above the $60-per-pound price that economists peg as necessary to encourage production, which has been trending higher. Higher prices and the prospect of fatter profits are only going to encourage uranium miners to mine more. What will higher production mean for the companies doing the producing? In the short term, it should mean higher profits as companies sell more uranium at higher prices. Rising prices have already turned profitable Cameco (last year), Uranium Royalty stock (this year), and Uranium Energy (last year, although it began losing money again this year). Ur-Energy, meanwhile, still hasn't booked an operating profit since 2018. As prices keep rising, there's a good chance more of these stocks will become more consistently profitable -- at least until rising production creates oversupply and starts driving prices back down again. This is a cyclical industry, after all, and investors can't enjoy a boom without anticipating a bust lying in wait just around the corner. So what's your best bet to play this trend? I have to think it's to buy Cameco first of all, while keeping a watchful eye on the others. Of the four uranium stocks discussed here, it's got the best record of profitability (having earned positive net profits in six of the past 10 years). It's also the only uranium stock currently generating positive free cash flow. At a price-to-free-cash-flow ratio of 45, Cameco stock is not cheap. But if you absolutely, positively feel you must invest in the uranium rally today, Cameco still seems the safest way to do that. Should you invest $1,000 in Cameco right now? Before you buy stock in Cameco, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Cameco wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $758,227!* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. TheStock Advisorservice has more than quadrupled the return of S&P 500 since 2002*. See the 10 stocks » *Stock Advisor returns as of August 22, 2024 Rich Smith has no position in any of the stocks mentioned. The Motley Fool recommends Cameco. The Motley Fool has a disclosure policy. Why Cameco, Ur-Energy, Uranium Royalty, and Uranium Energy Stocks Are Soaring Today was originally published by The Motley Fool
Why Cameco, Ur-Energy, Uranium Royalty, and Uranium Energy Stocks Are Soaring Today
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...